IMNM vs SPG · $2.47B cap vs rev $3.55B
Immunome Inc (IMNM) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Immunome Inc (IMNM) is a biotechnology company listed on US.
SPG (SPG) common stock.
Latest reported IMNM revenue for 2026-06-30 was $0. Net income was -$127.0M. IMNM currently screens at market cap $2.47B.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
IMNM currently screens at market cap $2.47B. SPG currently screens at market cap $0.
Not investment advice. Open the IMNM and SPG stock pages for the full models.
Not investment advice.